Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-005127
Filing Date
2024-02-23
Accepted
2024-02-23 18:59:58
Documents
1
Period of Report
2024-02-21

Document Format Files

Seq Description Document Type Size
1 form4-02232024_110241.html 4  
1 form4-02232024_110241.xml 4 14503
  Complete submission text file 0001415889-24-005127.txt   15911
Mailing Address C/O EPIZYME, INC. 400 TECHNOLOGY SQUARE, 4TH FLOOR CAMBRIDGE MA 02139
Business Address
Rhodes Jason P (Reporting) CIK: 0001577014 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39509 | Film No.: 24673165

Mailing Address 1560 TRAPELO ROAD WALTHAM MA 02451
Business Address 1560 TRAPELO ROAD WALTHAM MA 02451 (781) 786-8230
Dyne Therapeutics, Inc. (Issuer) CIK: 0001818794 (see all company filings)

EIN.: 364883909 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)